Management of Lumbar Pyogenic Spondylodiscitis in Germany: A Cross-Sectional Analysis of Spine Specialists

World Neurosurg. 2023 May:173:e663-e668. doi: 10.1016/j.wneu.2023.02.128. Epub 2023 Mar 7.

Abstract

Objective: The incidence of pyogenic spondylodiscitis is increasing, and the disease is associated with considerable morbidity, mortality, long-term healthcare utilization and societal costs. Disease-specific treatment guidelines are lacking and there is little consensus regarding optimal conservative and surgical management. This cross-sectional survey of German specialist spinal surgeons sought to determine practice patterns and degree of consensus regarding the management of lumbar pyogenic spondylodiscitis (LPS).

Methods: An electronic survey covering provider information, diagnostic approaches, treatment algorithms, and follow-up care of patients with LPS was distributed to members of the German Spine Society.

Results: Seventy-nine survey responses were included in the analysis. Magnetic resonance imaging is the diagnostic imaging modality of choice for 87% of respondents; 100% routinely measure C-reactive protein in suspected LPS and 70% routinely take blood cultures before therapy initiation; 41% believe that surgical biopsy to obtain microbiological diagnosis should be carried out in all cases of suspected LPS, whereas 23% believe that surgical biopsy should only be carried out when empirical antibiotic therapy proves ineffective; 38% believe an intraspinal empyema should always be surgically evacuated, regardless of spinal cord compression. The median intravenous antibiotic duration is 2 weeks. The median total duration of the antibiotic therapy (intravenous and oral) is 8 weeks. Magnetic resonance imaging is the preferred imaging modality for follow-up of both conservatively and operatively treated LPS.

Conclusions: There exists considerable variation of care in the diagnosis, management, and follow-up of LPS among German spine specialists with little agreement on key aspects of care. Further research is required to understand this variation in clinical practice and to enhance the evidence base in LPS.

Keywords: Antibiotics; Bacterial infections; Discitis; Lumbar spine; Osteomyelitis; Spondylitis; Spondylodiscitis.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cross-Sectional Studies
  • Discitis* / diagnosis
  • Discitis* / epidemiology
  • Discitis* / therapy
  • Humans
  • Lipopolysaccharides
  • Lumbar Vertebrae / surgery
  • Retrospective Studies
  • Spine / surgery
  • Treatment Outcome

Substances

  • Lipopolysaccharides
  • Anti-Bacterial Agents